Skip to content
DraconiticResearch
Search Sources API
190,869 studies31 sourcesUpdated 31 min ago
PreprintAll rights reservedmedRxiv

Tumour extrinsic neutrophil regulation in mesothelioma correlates with responsiveness to AXL and PD1 inhibition in MIST3, a phase IIA clinical trial

35 more authors
  1. 1CRUK Experimental Cancer Medicine Centre & NIHR Biomedical Research Centre, Mesothelioma Research Programme, University of Leicester, UK; Department of Oncology

Related

  1. PFKFB3 inhibition restores β-cell responsiveness to acetylcholine in a 3xTg-AD pancreatic tissue-slice mode
    J. Pfabe, S. Postic, L. Miglinci +8
    bioRxivPreprintCC BY-NC-NDFull textPhysiologybioRxiv
  2. Differential Regulation of Cholesterol-Related Gene Expression by HDAC Inhibition in Neuron-Enriched and Glia-Enriched Rat Primary Cultures
    Alevtina A. Samorodova, Alexander P. Beletskiy, Pavel M. Balaban +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Surgery & anaesthesiaCrossref
  3. Inhibition of PCSK9 protects against myocardial ischemia-reperfusion injury by suppressing ferroptosis via negative regulation of the P65/MMP9 pathway
    Jianan Xu, Shaohui Gao, Xuan Jiang +7
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  4. Pleural Mesothelioma with Net-like Structures
    Mika Horie, Daisuke Niino, Tamio Okimoto
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Modelling the efficacy of CAR-CIK cell immunotherapy targeting MET-expressing mesothelioma cells
    Federica Padovano, Andrea Maria Lombardi, Silvia Novello +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
BibTeX
@misc{fennell2026tumour,
  title = {{Tumour extrinsic neutrophil regulation in mesothelioma correlates with responsiveness to AXL and PD1 inhibition in MIST3, a phase IIA clinical trial}},
  author = {D. A. Fennell and J. Dzialo and M. Zhang and A. Bzura and C. Poile and E. Y. Baitei and M. Dungey and A. Branson and A. King and S. Barber and M. Antoniou and F. Maarawi and M. Jama and L. Darlison and M. Scotland and C. Belcher and A. Bajaj and B. Morgan and C. Brookes and D. Faulkner and J. Rogel and P. Wells -Jordan and C. J. Richards and J.-L. Luo and E. Darlington and L. Carter and M. Little and A. Greystoke and A. Thomas and M. Luckett and M. Abdullah and J. C. Hahne and Z. Zhou and H. Yang and S. Dulloo and K. Haldar and M. Barer and G. Griffiths and S. Ewings and K. Hill and E. Tulchinsky and N. A. Nusrat and N. C. Kuse and J. Monkman and R. Tubelleza and A. Kilgallon and Kul},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.22.26363540},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.22.26363540v1},
}
RIS
TY  - UNPB
TI  - Tumour extrinsic neutrophil regulation in mesothelioma correlates with responsiveness to AXL and PD1 inhibition in MIST3, a phase IIA clinical trial
AU  - D. A. Fennell
AU  - J. Dzialo
AU  - M. Zhang
AU  - A. Bzura
AU  - C. Poile
AU  - E. Y. Baitei
AU  - M. Dungey
AU  - A. Branson
AU  - A. King
AU  - S. Barber
AU  - M. Antoniou
AU  - F. Maarawi
AU  - M. Jama
AU  - L. Darlison
AU  - M. Scotland
AU  - C. Belcher
AU  - A. Bajaj
AU  - B. Morgan
AU  - C. Brookes
AU  - D. Faulkner
AU  - J. Rogel
AU  - P. Wells -Jordan
AU  - C. J. Richards
AU  - J.-L. Luo
AU  - E. Darlington
AU  - L. Carter
AU  - M. Little
AU  - A. Greystoke
AU  - A. Thomas
AU  - M. Luckett
AU  - M. Abdullah
AU  - J. C. Hahne
AU  - Z. Zhou
AU  - H. Yang
AU  - S. Dulloo
AU  - K. Haldar
AU  - M. Barer
AU  - G. Griffiths
AU  - S. Ewings
AU  - K. Hill
AU  - E. Tulchinsky
AU  - N. A. Nusrat
AU  - N. C. Kuse
AU  - J. Monkman
AU  - R. Tubelleza
AU  - A. Kilgallon
AU  - Kul
PY  - 2026
DA  - 2026/09/22
PB  - medRxiv
DO  - 10.64898/2026.09.22.26363540
UR  - https://www.medrxiv.org/content/10.64898/2026.09.22.26363540v1
ER  -